跳转至内容
Merck
CN

840875C

Avanti

二油酰磷脂酸(18:1 PA)

Avanti Polar Lipids

登录查看公司和协议定价

别名:
1,2-二-(9Z-十八烯酰)-sn-甘油-3-磷酸(钠盐);DOPA;PA (18:1 (9Z)/18:1 (9Z))
经验公式(希尔记法):
C39H72O8PNa
分子量:
722.95
UNSPSC代码:
51191904
NACRES:
NA.25

描述

1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt), chloroform solution

检测方案

>99% (TLC)

形式

liquid

包装

pkg of 1 × 2.5 mL (840875C-25mg)
pkg of 2 × 20 mL (840875C-1g)
pkg of 2 × 4 mL (840875C-200mg)
pkg of 5 × 4 mL (840875C-500mg)

制造商/商品名称

Avanti Polar Lipids

浓度

10 mg/mL (840875C-25mg)
25 mg/mL (840875C-1g)
25 mg/mL (840875C-200mg)
25 mg/mL (840875C-500mg)

脂质类型

cardiolipins
phospholipids

运输

dry ice

储存温度

−20°C

InChI

1S/C39H73O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h17-20,37H,3-16,21-36H2,1-2H3,(H2,42,43,44);/b19-17-,20-18-;/t37-;/m1./s1

InChI key

KHDHADSEKGCPKW-ZBFGHDQJSA-N

一般描述

二油酰磷脂酸(18:1 PA或1,2-二油酰-sn-甘油-3-磷酸钠盐)是以磷脂酸基团为骨架的修饰脂质的钠盐。

应用

二油酰磷脂酸(18:1 PA或1,2-二油酰-sn-甘油-3-磷酸钠盐)已用于:
  • 作为磷脂酸(PA)薄层色谱(TLC)分析的合成标准品,在碘染色后确定磷脂酸位置
  • 作为脂质标准品,用于优化液相色谱−质谱 (LC-MS)分析条件
  • 作为磷脂放射性标记分析的脂质标准品

生化/生理作用

磷脂酸(PA)起脂质信使作用。它在雷帕霉素(mTOR)信号转导的哺乳动物靶标中起关键作用。

包装

30 mL带螺旋盖的琥珀色窄口玻璃瓶(840875C-1g)
5 mL透明玻璃密封安瓿(840875C-200mg)
5 mL透明玻璃密封安瓿(840875C-25mg)
5 mL透明玻璃密封安瓿(840875C-500mg)

通常也和此产品一起购买

象形图

Skull and crossbonesHealth hazard

警示用语:

Danger

危险分类

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

靶器官

Central nervous system, Liver,Kidney

WGK

WGK 3

法规信息

危险化学品
易制毒化学品(2类)

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Xinhui Sun et al.
Cell cycle (Georgetown, Tex.), 14(5), 721-731 (2015-01-16)
It had been known for decades that primordial follicles in mammalian ovaries are assembled with definite numbers and represent the ovarian reserve throughout the reproductive life. Intra-oocyte PI3K/mTOR pathways have been indicated to play a central role on the activation
Shireesha Sankella et al.
The Journal of biological chemistry, 289(8), 4762-4777 (2014-01-16)
In this study we examined the role of phosphatidic acid (PA) in hepatic glucose production (HGP) and development of hepatic insulin resistance in mice that lack 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2). Liver lysophosphatidic acid and PA levels were increased ∼2- and
Shutao Guo et al.
Journal of controlled release : official journal of the Controlled Release Society, 174, 137-142 (2013-11-28)
The poor solubility of cisplatin (CDDP) often presents a major obstacle in the formulation of CDDP in nanoparticles (NPs) by traditional methods. We have developed a novel method for synthesizing CDDP NPs taking advantage of its poor solubility. By mixing
Kathleen Frondorf et al.
The Journal of biological chemistry, 285(21), 15837-15847 (2010-03-23)
Phosphatidic acid (PA) is a pleiotropic lipid second messenger in mammalian cells. We report here that extracellular PA acts as a leukocyte chemoattractant, as membrane-soluble dioleoyl-PA (DOPA) elicits actin polymerization and chemotaxis of human neutrophils and differentiated proleukemic HL-60 cells.
Reika Tei et al.
The Journal of cell biology, 219(3) (2020-01-31)
Phosphatidic acid (PA) is both a central phospholipid biosynthetic intermediate and a multifunctional lipid second messenger produced at several discrete subcellular locations. Organelle-specific PA pools are believed to play distinct physiological roles, but tools with high spatiotemporal control are lacking

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门